EW
INSM icon

Evoke Wealth’s Insmed INSM Stock Holding History

Evoke Wealth’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-200
Closed -$3.53K – 1337
2019
Q3 		$3.53K Buy
+200
New +$3.86K ﹤0.01% 1094

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Evoke Wealth's INSM Position: Q4 2019 in Review

Evoke Wealth sold out of Insmed (INSM) in Q4 2019, closing a stake of 200 shares — an estimated $3.53K sold.

Evoke Wealth first reported a position in INSM in Q3 2019 and held it in 1 quarter. The position peaked at $3.53K in Q3 2019. 176 funds tracked by Wall St. Rank hold INSM as of Q4 2019.

  • Evoke Wealth reported no remaining Insmed position as of Q4 2019 after selling out during the quarter.
  • Evoke Wealth sold 200 Insmed shares in Q4 2019, an estimated $3.53K.
  • Evoke Wealth first reported a position in Insmed in Q3 2019 and held it in 1 quarter.
  • Evoke Wealth's Insmed position peaked at $3.53K in Q3 2019.
  • 176 funds tracked by Wall St. Rank held Insmed as of Q4 2019.

Based on Evoke Wealth's 13F filing for Q4 2019, filed 7 Feb 2020.